Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Real-world evidence couples genomic biomarkers with therapeutic outcomes for canine hemangiosarcoma. | Sci Rep | 2025 | 40368987 | PubTator, text mining | PubMed |
| Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations. | Blood Adv | 2025 | 40367415 | PubTator, text mining | PubMed |
| Long term follow-up of multiorgan disease in Kleefstra syndrome 2 in an adult - case report. | BMC Neurol | 2025 | 40329253 | PubTator, text mining | PubMed |
| Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis. | ESMO Open | 2025 | 40305907 | PubTator, text mining | PubMed |
| Genetic Etiology of Epilepsy: A Retrospective Study From a Single-Center Cohort. | Clin Genet | 2025 | 40296287 | PubTator, text mining | PubMed |
| KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy. | Cancer Cell | 2025 | 40280125 | PubTator, text mining | PubMed |
The Application of Liquid Biopsy for the Development and Validation of a Non-Invasive Screening and Diagnosis Test for Endometrial Premalignant and Malignant Lesions: A Prospective Innovative Pilot Study. | Cancers (Basel) | 2025 | 40227624 | PubTator, text mining | PubMed |
| Clinicopathologic and Molecular Analysis of Malignant Neoplasms With Yolk Sac Tumor Differentiation in Women 40 Years of Age and Older. | Am J Surg Pathol | 2025 | 40202333 | PubTator, text mining | PubMed |
| Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty. | Eur J Endocrinol | 2025 | 40193575 | PubTator, text mining | PubMed |
| Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study. | Mol Diagn Ther | 2025 | 40192953 | PubTator, text mining | PubMed |
| Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation Landscape. | Onco Targets Ther | 2025 | 40177613 | PubTator, text mining | PubMed |
| KMT2C mutation in sporadic cribriform morular thyroid carcinoma: A rare case report and review of literature. | J Int Med Res | 2025 | 40173034 | PubTator, text mining | PubMed |
| Fetal context conveys heritable protection against MLL-rearranged leukemia that depends on MLL3. | bioRxiv | 2025 | 40161712 | PubTator, text mining | PubMed |
| Primary Failure of Eruption: A Rare but Desperate Condition for Orthodontic Treatment. | Turk J Orthod | 2025 | 40150885 | PubTator, text mining | PubMed |
| The Status of SOX2 Expression in Gastric Cancers with Induction of CDX2 Defines Groups with Different Genomic Landscapes. | Genes (Basel) | 2025 | 40149431 | PubTator, text mining | PubMed |
| Real-World Data Analysis of Genomic Alterations Detected by a Dual DNA-RNA Comprehensive Genomic Profiling Test. | Cancer Sci | 2025 | 40140952 | PubTator, text mining | PubMed |
| Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers. | Clin Lung Cancer | 2025 | 40064574 | PubTator, text mining | PubMed |
| Syndromic and Non-Syndromic Primary Failure of Tooth Eruption: A Genetic Overview. | Genes (Basel) | 2025 | 40004475 | PubTator, text mining | PubMed |
| The MLL3/GRHL2 complex regulates malignant transformation and anti-tumor immunity in squamous cancer. | J Exp Med | 2025 | 39964485 | PubTator, text mining | PubMed |
| KMT2C/KMT2D-dependent H3K4me1 mediates changes in DNA replication timing and origin activity during a cell fate transition. | Cell Rep | 2025 | 39908143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=9